Latest Bill & Melinda Gates Foundation Stories
AUSTIN, Texas, Jan. 8, 2013 /PRNewswire/ -- SXSWedu Conference today announced that Bill Gates will deliver the closing keynote address at the 2013 SXSWedu Conference. Gates, co-chair of the Bill & Melinda Gates Foundation, will address the foundation's U.S. education work, which focuses primarily on ensuring all students are prepared for success in college and career. The keynote will take place 10:30 a.m. Thursday, March 7, 2013 in Ballroom D of the Austin Convention Center in...
BOSTON, Dec. 4, 2012 /PRNewswire-USNewswire/ -- Boston Children's Hospital announced today that it will receive a $1.7M grant through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and better health solutions for the developing world. Christopher Duggan, MD, MPH , director of Boston...
Affordable, safe, effective vaccine protecting young people from devastating disease GENEVA, Dec. 3, 2012 /PRNewswire-USNewswire/ -- A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa's "meningitis belt," where the country is conducting its second seasonal immunisation campaign against the disease....
NEW YORK, Nov. 28, 2012 /PRNewswire/ -- The Jeffrey Modell Foundation (JMF), a global non-profit organization dedicated to early diagnosis, proper treatment, and public awareness of genetic immune deficiency diseases, known as Primary Immunodeficiencies (PI), today announced a working collaboration with the Bill & Melinda Gates Foundation to achieve a common goal to end polio worldwide. To view the multimedia assets associated with this release, please click...
Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Researchers at Weill Cornell have been awarded three research grants totaling more than $1.5 million. Weill Cornell's Dr. Juan R. Cubillos-Ruiz, a postdoctoral research associate in medicine in the laboratory of Dean Dr. Laurie H. Glimcher, will pursue an innovative global health and development research project titled, "Tailored...
Gates Foundation's Grand Challenges Explorations grants invest in bold ideas to address global health and development challenges SEATTLE, Nov. 1, 2012 /PRNewswire-USNewswire/ -- The Bill & Melinda Gates Foundation today announced more than $21 million US in new grants through its Grand Challenges Explorations (GCE) initiative. GCE is a tiered granting mechanism that funds innovative ideas to tackle key global health and development problems, and provides additional resources for...
WASHINGTON, Oct. 24, 2012 /PRNewswire-USNewswire/ -- The Frontline Health Workers Coalition has received a $750,000 grant from the Bill & Melinda Gates Foundation, awarded to coalition member IntraHealth International, to support the group's mission to urge greater and more strategic U.S. investment in frontline health workers in developing countries. Building this workforce is the most cost-effective way to save lives and foster a healthier, safer, more prosperous world, the...
'World's Biggest Commercial,' 'End Polio Now' album highlight humanitarian group's public outreach in support of global effort to end a crippling disease once and for all EVANSTON, Ill., Oct. 18, 2012 /PRNewswire-USNewswire/ -- On World Polio Day (Oct. 24), Rotary International invites one and all to get online and participate in the World's Biggest Commercial, promoting the global effort to eradicate this crippling childhood disease. The innovative, interactive campaign gives...
Phase IIb Proof of Concept Trial Planned for Kenya, India and South Africa ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire-USNewswire/ -- Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01(E)(*) adjuvant. This novel research and resource-sharing agreement between the largest non-profit TB vaccine biotech and...
LONDON, Oct. 9, 2012 /PRNewswire/ -- In an interview with Philanthropy Management, "Philanthrocapitalism" co-author Michael Green laments that fundamental constraints keep governments from acting as a catalyst for philanthropic innovation. According to Green, a major obstacle that hampers popularly-elected governments is what he terms philanthropic "attention deficit." Due to frequent elections, politicians see little upside to supporting philanthropic initiatives that might upset...
